Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at an advanced stage the sputum will contain blood and other symptoms include lack of appetite, weight loss, fever, and night sweats.
Scope of the Report:
America holds the largest market share of TB vaccines due to the major market players are concentrated and its emphasis on vaccination against TB.
The global Tuberculosis Vaccine Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Tuberculosis Vaccine Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Tuberculosis Vaccine Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Tuberculosis Vaccine Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Sanofi
Merck
Serum Institute of India
GlaxoSmithKline
Japan BCG Lab
IDT Biologics
GreenSignal Bio Pharma
Taj Pharmaceuticals
Bavarian Nordic
China National Biotec Group
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Immunotherapeutic Vaccines
Booster Vaccines
Others
Market Segment by Applications, can be divided into
Hospitals
Clinics
Research Institutes
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Tuberculosis Vaccine Treatment Market Overview
1.1 Product Overview and Scope of Tuberculosis Vaccine Treatment
1.2 Classification of Tuberculosis Vaccine Treatment by Types
1.2.1 Global Tuberculosis Vaccine Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Types in 2017
1.2.3 Immunotherapeutic Vaccines
1.2.4 Booster Vaccines
1.2.5 Others
1.3 Global Tuberculosis Vaccine Treatment Market by Application
1.3.1 Global Tuberculosis Vaccine Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institutes
1.3.5 Others
1.4 Global Tuberculosis Vaccine Treatment Market by Regions
1.4.1 Global Tuberculosis Vaccine Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Tuberculosis Vaccine Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Tuberculosis Vaccine Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Tuberculosis Vaccine Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Tuberculosis Vaccine Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Tuberculosis Vaccine Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Tuberculosis Vaccine Treatment (2013-2023)
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Business Overview
2.1.2 Tuberculosis Vaccine Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi Tuberculosis Vaccine Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
2.2.1 Business Overview
2.2.2 Tuberculosis Vaccine Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Tuberculosis Vaccine Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Serum Institute of India
2.3.1 Business Overview
2.3.2 Tuberculosis Vaccine Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 GlaxoSmithKline
2.4.1 Business Overview
2.4.2 Tuberculosis Vaccine Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 GlaxoSmithKline Tuberculosis Vaccine Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Japan BCG Lab
2.5.1 Business Overview
2.5.2 Tuberculosis Vaccine Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Japan BCG Lab Tuberculosis Vaccine Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 IDT Biologics
2.6.1 Business Overview
2.6.2 Tuberculosis Vaccine Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 IDT Biologics Tuberculosis Vaccine Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 GreenSignal Bio Pharma
2.7.1 Business Overview
2.7.2 Tuberculosis Vaccine Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Taj Pharmaceuticals
2.8.1 Business Overview
2.8.2 Tuberculosis Vaccine Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.9 Bavarian Nordic
2.9.1 Business Overview
2.9.2 Tuberculosis Vaccine Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bavarian Nordic Tuberculosis Vaccine Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.10 China National Biotec Group
2.10.1 Business Overview
2.10.2 Tuberculosis Vaccine Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 China National Biotec Group Tuberculosis Vaccine Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Tuberculosis Vaccine Treatment Market Competition, by Players
3.1 Global Tuberculosis Vaccine Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Tuberculosis Vaccine Treatment Players Market Share
3.2.2 Top 10 Tuberculosis Vaccine Treatment Players Market Share
3.3 Market Competition Trend
4 Global Tuberculosis Vaccine Treatment Market Size by Regions
4.1 Global Tuberculosis Vaccine Treatment Revenue and Market Share by Regions
4.2 North America Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
5 North America Tuberculosis Vaccine Treatment Revenue by Countries
5.1 North America Tuberculosis Vaccine Treatment Revenue by Countries (2013-2018)
5.2 USA Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
6 Europe Tuberculosis Vaccine Treatment Revenue by Countries
6.1 Europe Tuberculosis Vaccine Treatment Revenue by Countries (2013-2018)
6.2 Germany Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
6.4 France Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Tuberculosis Vaccine Treatment Revenue by Countries
7.1 Asia-Pacific Tuberculosis Vaccine Treatment Revenue by Countries (2013-2018)
7.2 China Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
7.5 India Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
8 South America Tuberculosis Vaccine Treatment Revenue by Countries
8.1 South America Tuberculosis Vaccine Treatment Revenue by Countries (2013-2018)
8.2 Brazil Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Tuberculosis Vaccine Treatment by Countries
9.1 Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Tuberculosis Vaccine Treatment Revenue and Growth Rate (2013-2018)
10 Global Tuberculosis Vaccine Treatment Market Segment by Type
10.1 Global Tuberculosis Vaccine Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Tuberculosis Vaccine Treatment Market Forecast by Type (2018-2023)
10.3 Immunotherapeutic Vaccines Revenue Growth Rate (2013-2023)
10.4 Booster Vaccines Revenue Growth Rate (2013-2023)
10.5 Others Revenue Growth Rate (2013-2023)
11 Global Tuberculosis Vaccine Treatment Market Segment by Application
11.1 Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2013-2018)
11.2 Tuberculosis Vaccine Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Research Institutes Revenue Growth (2013-2018)
11.6 Others Revenue Growth (2013-2018)
12 Global Tuberculosis Vaccine Treatment Market Size Forecast (2018-2023)
12.1 Global Tuberculosis Vaccine Treatment Market Size Forecast (2018-2023)
12.2 Global Tuberculosis Vaccine Treatment Market Forecast by Regions (2018-2023)
12.3 North America Tuberculosis Vaccine Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Tuberculosis Vaccine Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Tuberculosis Vaccine Treatment Revenue Market Forecast (2018-2023)
12.6 South America Tuberculosis Vaccine Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Tuberculosis Vaccine Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Tuberculosis Vaccine Treatment Picture
Table Product Specifications of Tuberculosis Vaccine Treatment
Table Global Tuberculosis Vaccine Treatment and Revenue (Millio